Therapeutic targeting of autophagy in neurodegenerative and infectious diseases

185Citations
Citations of this article
254Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Autophagy is a conserved process that uses double-membrane vesicles to deliver cytoplasmic contents to lysosomes for degradation. Although autophagy may impact many facets of human biology and disease, in this review we focus on the ability of autophagy to protect against certain neurodegenerative and infectious diseases. Autophagy enhances the clearance of toxic, cytoplasmic, aggregate-prone proteins and infectious agents. The beneficial roles of autophagy can now be extended to supporting cell survival and regulating inflammation. Autophagic control of inflammation is one area where autophagy may have similar benefits for both infectious and neurodegenerative diseases beyond direct removal of the pathogenic agents. Preclinical data supporting the potential therapeutic utility of autophagy modulation in such conditions is accumulating.

Cite

CITATION STYLE

APA

Rubinsztein, D. C., Bento, C. F., & Deretic, V. (2015, June 29). Therapeutic targeting of autophagy in neurodegenerative and infectious diseases. Journal of Experimental Medicine. Rockefeller University Press. https://doi.org/10.1084/jem.20150956

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free